Amazing presentation by Juan Alderuccio at ASH clearly showing that Lonca T and rituxan as a new option for poor risk first relapse Follicular lymphomas
Great day for our Sylvester
Over 6500 participants walking or running or riding at the dolphins challenge cancer event where all donations go directly for cancer research and I am so proud to be part of our faculty and our team cure lymphoma now!
Please take asco abim survey it is critical, once again why does an oncology sub specialist need to know general med oncology?
Seeing only Lymphoma pts for 30 years should exclude me from all questions other than Lymphoma!
@AaronGoodman33 it makes no sense for an oncologist subspeciaiist to do these tests
Why would a doc that has seen only lymphoma for 3O years need to Learn ovarian care management!
It may be premature to state nivo avd is the new standard in advanced stage HL
Letโs see the data with a medium follow up of 2 years, however the data thus far is amazing!
Presenting the Lifestyle Intervention of Food and Exercise in Lymphoma patients (LIFE-L) protocol at #AACR2023. This pilot randomized trial seeks to improve treatment adherence and completion through a Mediterranean diet and exercise intervention๐ฅ๐ช
What at day for the Sylvester comprehensive cancer center family with 5600 folks participating in the dolphins challenge cancer event and I am proud to be a member!
@tobyeyre82 My view is that intensive induction that contains ara c and ibrutinib is the clear winner and asct is likely no longer necessary in the managment of MCL with cart and bispecifics available for relapse